📇 Rhumatologue · BAYONNE CEDEX · (64) · Salarié
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
42 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
166.7 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CH COTE BASQUE
13 AV DE L'INTERNE JACQUES LOEB BP 8, 64109 BAYONNE CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Annals of the rheumatic diseases · 2023
Nature genetics · 2024
Arthritis & rheumatology (Hoboken, N.J.) · 2023
ObjectiveCalcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have developed the first‐ever validated classification criteria for symptomatic CPPD disease.MethodsSupported by the ACR and EULAR, a multinational group of investigators followed established methodology to develop these disease classification criteria. The group generated lists of candidate items and refined their definitions, collected de‐identified patient profiles, evaluated strengths of associations between candidate items and CPPD disease, developed a classification criteria framework, and used multi‐criterion decision analysis to define criteria weights and a classification threshold score. The criteria were validated in an independent cohort.ResultsAmong patients with joint pain, swelling, or tenderness (entry criterion) whose symptoms are not fully explained by an alternative disease (exclusion criterion), the presence of crowned dens syndrome or calcium pyrophosphate crystals in synovial fluid are sufficient to classify a patient as having CPPD disease. In the absence of these findings, a score >56 points using weighted criteria, comprising clinical features, associated metabolic disorders, and results of laboratory and imaging investigations, can be used to classify as CPPD disease. These criteria had a sensitivity of 92.2% and specificity of 87.9% in the derivation cohort (190 CPPD cases, 148 mimickers), whereas sensitivity was 99.2% and specificity was 92.5% in the validation cohort (251 CPPD cases, 162 mimickers).ConclusionThe 2023 ACR/EULAR CPPD disease classification criteria have excellent performance characteristics and will facilitate research in this field.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Annals of the rheumatic diseases · 2026 · Journal Article
Stewart S, Gamble GD, Taylor WJ, Harrison A, et al.
Clinical and experimental rheumatology · 2026 · Journal Article
Rodríguez-Alvear C, Calabuig I, Martínez-Sanchis A, Andrés M
Journal of clinical medicine · 2026 · Journal Article
Mora-Vázquez P, Borrás F, De Miguel E, Picó A, et al.
Frontiers in medicine · 2025 · Journal Article
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Peral-Garrido ML, Gómez-Sabater S, Caño R, Bermúdez-García A, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Editorial
Andrés M
BMJ open · 2024 · Journal Article
Stewart S, Gamble G, Taylor W, Su I, et al.
Nature genetics · 2024 · Published Erratum
Major TJ, Takei R, Matsuo H, Leask MP, et al.
Nature genetics · 2024 · Journal Article
Major TJ, Takei R, Matsuo H, Leask MP, et al.
Communications biology · 2024 · Journal Article
Rodriguez-Navarro C, Elert K, Ibañez-Velasco A, Monasterio-Guillot L, et al.
International journal of rheumatic diseases · 2023 · Journal Article
Calabuig I, Marty-Ané A, Norberciak L, Budzik JF, et al.
RMD open · 2023 · Observational Study
Rodríguez-Sosa E, De Miguel E, Borrás F, Andrés M
Joint bone spine · 2023 · Editorial
Pascual E, Peral-Garrido ML, Andrés M
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Sumpter NA, Takei R, Cadzow M, Topless RKG, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2022 · Journal Article
Ruiz-Simón S, Calabuig I, Gómez-Garberí M, Andrés M
Therapeutic advances in musculoskeletal disease · 2022 · Journal Article
Sivera F, Andres M, Dalbeth N
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · Letter
Dalbeth N, Alhilali M, Riordan P, Narang R, et al.
Annals of the rheumatic diseases · 2022 · Letter
Quilis N, Vela P, Blanco Cáceres BA, Diaz-Torne C, et al.
Reumatologia clinica · 2022 · Journal Article
Ferrández-Jiménez M, Calabuig I, Peral-Garrido ML, Gómez-Garberí M, et al.
Reumatologia clinica · 2022 · Letter
Andrés M, Begazo A, Sivera F, Vela P, et al.
Frontiers in medicine · 2021 · Journal Article
Calabuig I, Martínez-Sanchis A, Andrés M
The Cochrane database of systematic reviews · 2021 · Journal Article
Andrés M, Sivera F, Buchbinder R, Pardo Pardo J, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · Journal Article
Pascart T, Latourte A, Tedeschi SK, Dalbeth N, et al.
Annals of the rheumatic diseases · 2023 · Journal Article
Mascaro JM, Rodriguez-Pinto I, Poza G, Mensa-Vilaro A, et al.
Arthritis care & research · 2025 · Journal Article
De Lorenzis E, Natalello G, De Angelis R, Verardi L, et al.
Seminars in arthritis and rheumatism · 2024 · Journal Article
Peral-Garrido ML, Gómez-Sabater S, Caño R, Bermúdez-García A, et al.
Annals of the rheumatic diseases · 2022 · Letter
Jovani V, Calabuig I, Peral-Garrido ML, Tovar-Sugrañes E, et al.
Journal of clinical medicine · 2024 · Journal Article
Paroli M, Becciolini A, Lo Gullo A, Parisi S, et al.
Rheumatology (Oxford, England) · 2024 · Journal Article
Damart J, Filippou G, Andrès M, Cipolletta E, et al.
Osteoarthritis and cartilage · 2025 · Journal Article
Gaspar MG, Núñez-Carro C, Blanco-Blanco M, Blanco FJ, et al.
Annals of the rheumatic diseases · 2023 · Meta-Analysis
Durán-Sotuela A, Fernandez-Moreno M, Suárez-Ulloa V, Vázquez-García J, et al.
Pediatric rheumatology online journal · 2024 · Journal Article
Quilis N, Mesa-Del-Castillo Bermejo P, Boix P, Juanola O, et al.
Clinical and experimental rheumatology · 2024 · Journal Article
La Barbera L, Rizzo C, Camarda F, Atzeni F, et al.
The Lancet. Rheumatology · 2026 · Journal Article
Tani C, Cardelli C, Moroni L, Zen M, et al.
Osteoarthritis and cartilage · 2025 · Journal Article
Gaspar MG, Núñez-Carro C, Blanco-Blanco M, Blanco FJ, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Cipolletta E, Rozza D, Andres M, Ottaviani S, et al.
Osteoarthritis and cartilage · 2025 · Journal Article
Gaspar MG, Núñez-Carro C, Blanco-Blanco M, Blanco FJ, et al.
Seminars in arthritis and rheumatism · 2025 · Journal Article
Moreno-Pérez O, Tejera-Muñoz A, Carreño-Valdivia R, Rodríguez-Bedoya M, et al.
Annals of the rheumatic diseases · 2023 · Journal Article
Abhishek A, Tedeschi SK, Pascart T, Latourte A, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Abhishek A, Tedeschi SK, Pascart T, Latourte A, et al.
Antioxidants (Basel, Switzerland) · 2023 · Journal Article
Muñoz-García R, Sánchez-Hidalgo M, Alcarranza M, Vazquéz-Román MV, et al.
Joint bone spine · 2022 · Journal Article
Andrés M, Mendieta L, Argente-Del-Castillo E, Trigueros M, et al.
Arthritis care & research · 2022 · Journal Article
Tedeschi SK, Pascart T, Latourte A, Godsave C, et al.
International journal of molecular sciences · 2022 · Journal Article
Núñez-Carro C, Blanco-Blanco M, Montoya T, Villagrán-Andrade KM, et al.